Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    " April 09, 2008":" May 09, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP
Condition: HIV Infections
Intervention: Drug: AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP
2 Completed HIV Vertical Transmission in Vietnam
Condition: HIV Infections
Intervention:
3 Completed Qualitative and Quantitative HIV RNA Detection in Saliva Using the Oragene RNA Kit
Condition: HIV Infections
Intervention:
4 Completed Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Tenofovir/Emtricitabine
5 Completed A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744
Condition: HIV Infection
Intervention: Drug: GSK1265744
6 Completed Enhancing Communication and HIV Outcomes
Condition: HIV Infections
Intervention: Behavioral: communication training
7 Completed Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir
8 Completed Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Emtricitabine/tenofovir disoproxil fumarate
9 Completed China Adherence for Life
Condition: HIV Infections
Intervention: Behavioral: Electronic drug monitoring feedback intervention
10 Completed An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment
Condition: HIV Infections
Intervention: Drug: elvucitabine
11 Unknown  Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda
Condition: HIV Infections
Interventions: Drug: cotrimoxazole;   Drug: Placebo
12 Active, not recruiting Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon
Condition: HIV Infections
Interventions: Drug: Treatment initiation for HIV-1 group O infected patients;   Drug: Treatment initiation for HIV-1 group M infected patients
13 Completed Phase II Study of AGS‑004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV
Condition: HIV Infections
Intervention: Biological: AGS-004
14 Suspended Bioequivalence Study of Didanosine in Children Treated for HIV
Condition: HIV Infections
Intervention: Drug: didanosine
15 Completed Impact of Peer Health Workers and Mobile Phones on HIV Care
Condition: HIV Infections
Interventions: Behavioral: Peer Health Workers Intervention;   Behavioral: Peer Health Workers and Mobile Phone Intervention
16 Completed Rapid HIV Testing for Emergency Department Patients
Condition: HIV Infections
Intervention: Behavioral: HIV risk education
17 Completed
Has Results
Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients
Condition: HIV Infections
Intervention: Drug: raltegravir
18 Completed Raltegravir as Early Therapy in African-Americans Living With HIV Study
Condition: HIV Infections
Intervention: Drug: Raltegravir + Truvada
19 Completed
Has Results
Aging & HIV/AIDS Neurocognitive Sequelae and Functional Consequences
Condition: HIV Infections
Intervention:
20 Completed Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand
Condition: HIV Infections
Interventions: Drug: GPO-Vir Z30 tablet;   Drug: Lamivudine;   Drug: Nevirapine;   Drug: Zidovudine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.